We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.
- Authors
Routledge, Isobel; Epstein, Adrienne; Takahashi, Saki; Janson, Owen; Hakim, Jill; Duarte, Elias; Turcios, Keirstinne; Vinden, Joanna; Sujishi, Kirk; Rangel, Jesus; Coh, Marcelina; Besana, Lee; Ho, Wai-Kit; Oon, Ching-Ying; Ong, Chui Mei; Yun, Cassandra; Lynch, Kara; Wu, Alan H. B.; Wu, Wesley; Karlon, William
- Abstract
Serosurveillance provides a unique opportunity to quantify the proportion of the population that has been exposed to pathogens. Here, we developed and piloted Serosurveillance for Continuous, ActionabLe Epidemiologic Intelligence of Transmission (SCALE-IT), a platform through which we systematically tested remnant samples from routine blood draws in two major hospital networks in San Francisco for SARS-CoV-2 antibodies during the early months of the pandemic. Importantly, SCALE-IT allows for algorithmic sample selection and rich data on covariates by leveraging electronic health record data. We estimated overall seroprevalence at 4.2%, corresponding to a case ascertainment rate of only 4.9%, and identified important heterogeneities by neighborhood, homelessness status, and race/ethnicity. Neighborhood seroprevalence estimates from SCALE-IT were comparable to local community-based surveys, while providing results encompassing the entire city that have been previously unavailable. Leveraging this hybrid serosurveillance approach has strong potential for application beyond this local context and for diseases other than SARS-CoV-2. Population-based surveys are the gold standard for estimating seroprevalence but are expensive and often only capture a small geographic area or window of time. This study describes a new platform, SCALE-IT, for serosurveillance based on algorithmic sampling of electronic health records, and uses it to estimate the seroprevalence of SARS-CoV-2 in San Francisco.
- Subjects
SAN Francisco (Calif.); ELECTRONIC health records; SARS-CoV-2; SEROPREVALENCE; ETHNICITY
- Publication
Nature Communications, 2021, Vol 12, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-021-23651-6